4.5 Review

Impact of standardised review of intravenous antibiotic therapy 72 hours after prescription in two internal medicine wards

Journal

JOURNAL OF HOSPITAL INFECTION
Volume 74, Issue 4, Pages 326-331

Publisher

W B SAUNDERS CO LTD
DOI: 10.1016/j.jhin.2009.07.011

Keywords

Antibiotic consumption; Antimicrobial stewardship; Quality of healthcare

Funding

  1. Swiss National Science Foundation [32-63128.00]
  2. Centre Hospitaller Universitaire Vaudois, Lausanne, Switzerland

Ask authors/readers for more resources

Post-prescription review of hospital antibiotic therapy may contribute to more appropriate use. We estimated the impact of a standardised review of intravenous antibiotic therapy three days after prescription in two internal medicine wards of a university hospital. In one ward, we assessed the charts of patients under intravenous antibiotic therapy using a standardised review process and provided feedback to the prescriber. There was no intervention in the other ward. After six months we crossed the allocation between the two wards. In all, 204 courses of antibiotic therapy were included in the intervention periods and 226 in the control periods. Post-prescription review led to proposals for modification in 46% of antibiotic courses. Time to treatment modification was 22% shorter in the intervention periods compared with the control periods (3.9 +/- 5.2 days vs 5.0 +/- 6.0 days, P = 0.007). Patients included in the intervention group had lower antibiotic consumption than patients in the control group, but the intervention had no significant impact on the overall antibiotic consumption of the two wards. (C) 2009 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Increasing Frequency and Transmission of HIV-1 Non-B Subtypes Among Men Who Have Sex With Men in the Swiss HIV Cohort Study

Jessy J. Duran Ramirez, Tala Ballouz, Huyen Nguyen, Katharina Kusejko, Sandra E. Chaudron, Michael Huber, Hans H. Hirsch, Matthieu Perreau, Alban Ramette, Sabine Yerly, Matthias Cavassini, Marcel Stockle, Hansjakob Furrer, Pietro Vernazza, Enos Bernasconi, Huldrych F. Gunthard, Roger D. Kouyos

Summary: The study reveals a significant increase in non-B subtypes of HIV-1 among men who have sex with men (MSM) in Switzerland, with CRF01_AE being the most prevalent subtype. The majority of molecular transmission clusters (MTCs) among MSM were found to be comprised of Europeans.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Public, Environmental & Occupational Health

Female Genital Mutilation/Cutting in the Swiss HIV Cohort Study: A Cross-Sectional Study

Fabio Mauri, Sara Cottler-Casanova, Matthias Cavassini, Marcel Stoeckle, Gilles Wandeler, Patrick Schmid, Dominique L. Braun, Alexandra Scherrer, Enos Bernasconi, Alexandra Calmy, Jasmine Abdulcadir

Summary: FGM/C is a harmful practice that involves injury to the female genitalia without medical purpose, and it is prevalent worldwide. There is a lack of knowledge on how to care for women with FGM/C, and improvements in care and prevention are needed.

JOURNAL OF IMMIGRANT AND MINORITY HEALTH (2023)

Article Immunology

The deficiency in Th2-like Tfh cells affects the maturation and quality of HIV-specific B cell response in viremic infection

Alessandra Noto, Madeleine Suffiotti, Victor Joo, Antonio Mancarella, Francesco A. A. Procopio, Guy Cavet, Yvonne Leung, Jean-Marc Corpataux, Matthias Cavassini, Agostino Riva, Leonidas Stamatatos, Raphael Gottardo, Adrian B. B. McDermott, Richard A. A. Koup, Craig Fenwick, Matthieu Perreau, Giuseppe Pantaleo

Summary: The imbalance between Th2 and Th1-like Tfh cells affects B cell responses in viremic HIV infection. The decrease in Th2-like Tfh cells is related to the decrease in HIV-specific B cells, while the increase in Th1-like Tfh cells is associated with the increase in T-bet and CXCR3 expressing HIV-specific B cells. IL-4 and IL-21 cytokines promote efficient maturation of HIV-specific B cells, while IFN-gamma induces the expression of T-bet and CXCR3 in B cells. CXCR3(+) B cells have a lower rate of somatic hypermutation compared to CXCR3(-) B cells.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Quantifying and Predicting Ongoing Human Immunodeficiency Virus Type 1 Transmission Dynamics in Switzerland Using a Distance-Based Clustering Approach

Marco Labarile, Tom Loosli, Marius Zeeb, Katharina Kusejko, Michael Huber, Hans H. Hirsch, Matthieu Perreau, Alban Ramette, Sabine Yerly, Matthias Cavassini, Manuel Battegay, Andri Rauch, Alexandra Calmy, Julia Notter, Enos Bernasconi, Christoph Fux, Huldrych F. Gunthard, Chloe Pasin, Roger D. Kouyos

Summary: This study investigated and predicted the dynamics of HIV transmission in Switzerland using a network-based clustering method and statistical learning approaches. The study found that network characteristics can capture major heterogeneities in transmission and that cluster structure has the potential for real-time prediction of ongoing transmission.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Immunology

Outcomes of SARS-CoV-2 infection among lung transplant recipients: A single center retrospective study

Alessio Casutt, Matthaios Papadimitriou-Olivgeris, Foteini Ioakeim, John-David Aubert, Oriol Manuel, Angela Koutsokera

Summary: This study investigated the outcomes of COVID-19 infection in lung transplant recipients and found that they are at increased risk for complications. The administration of monoclonal antibodies as early treatment was associated with a lower risk, while age over 60 years was associated with a higher risk.

TRANSPLANT INFECTIOUS DISEASE (2023)

Editorial Material Immunology

Preemptive therapy versus universal prophylaxis: Time for reconciliation?

Eleftheria Kampouri, Oriol Manuel

TRANSPLANT INFECTIOUS DISEASE (2023)

Article Pharmacology & Pharmacy

Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor-containing regimen

Catia Marzolini, Matthias L. Cavassini, Dominique L. Braun, Anna Hachfeld, Enos Bernasconi, Alexandra Calmy, Patrick Schmid, Manuel Battegay, Luigia Elzi

Summary: This study aimed to investigate whether a common single polymorphism could explain the phenomenon of some HIV patients not achieving their lipid targets despite elevated statin concentrations. The study found that individuals carrying the SLCO1B1 c.521T>C polymorphism had smaller changes in lipid levels after statin initiation compared to those without this polymorphism.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Infectious Diseases

Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration

Paul Thoueille, Susana Alves Saldanha, Vincent Desfontaine, Katharina Kusejko, Perrine Courlet, Pascal Andre, Matthias Cavassini, Laurent A. Decosterd, Thierry Buclin, Monia Guidi

Summary: This study investigated the pharmacokinetics of tenofovir alafenamide (TAF) in people living with HIV (PLWH), and found that renal function significantly affects TAF exposure. The study suggests cautious adjustment of TAF dosage intervals in case of moderate or severe chronic kidney disease (CKD).

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Immunology

Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial

Oriol Manuel, Mirjam Laager, Cedric Hirzel, Dionysios Neofytos, Laura N. Walti, Gideon Hoenger, Isabelle Binet, Aurelia Schnyder, Susanne Stampf, Michael Koller, Matteo Mombelli, Min Jeong Kim, Matthias Hoffmann, Katrin Koenig, Christoph Hess, Anne-Valerie Burgener, Pietro E. Cippa, Kerstin Huebel, Thomas F. Mueller, Daniel Sidler, Suzan Dahdal, Franziska Suter-Riniker, Jean Villard, Andrea Zbinden, Giuseppe Pantaleo, Nasser Semmo, Karine Hadaya, Natalia Enriquez, Pascal R. Meylan, Marc Froissart, Dela Golshayan, Thomas Fehr, Uyen Huynh-Do, Manuel Pascual, Christian van Delden, Hans H. Hirsch, Peter Jueni, Nicolas J. Mueller, Swiss Transplant Cohort Study STCS

Summary: This study examined the use of immune monitoring to individualize the duration of antiviral prophylaxis after transplantation. The results showed that immune monitoring led to a significant reduction in prophylaxis duration, but did not establish noninferiority in terms of the primary outcome of CMV infection.

CLINICAL INFECTIOUS DISEASES (2023)

Article Immunology

Immunogenicity of High-Dose Versus MF59-Adjuvanted Versus Standard Influenza Vaccine in Solid Organ Transplant Recipients: The Swiss/Spanish Trial in Solid Organ Transplantation on Prevention of Influenza (STOP-FLU Trial)

Matteo Mombelli, Dionysios Neofytos, Uyen Huynh-Do, Javier Sanchez-Cespedes, Susanne Stampf, Dela Golshayan, Suzan Dahdal, Guido Stirnimann, Aurelia Schnyder, Christian Garzoni, Reto M. Venzin, Lorenzo Magenta, Melanie Schonenberger, Laura Walti, Cedric Hirzel, Aline Munting, Michael Dickenmann, Michael Koller, John-David Aubert, Jurg Steiger, Manuel Pascual, Thomas F. Mueller, Mace Schuurmans, Christoph Berger, Isabelle Binet, Jean Villard, Nicolas J. Mueller, Adrian Egli, Elisa Cordero, Christian van Delden, Oriol Manuel

Summary: The use of MF59-adjuvanted or high-dose influenza vaccine in solid-organ transplant recipients was safe and resulted in a higher vaccine response rate.

CLINICAL INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018

Bashkim Jaha, Corinne D. Schenkel, Lisa Jorimann, Michael Huber, Maryam Zaheri, Kathrin Neumann, Christine Leemann, Alexandra Calmy, Matthias Cavassini, Roger D. Kouyos, Huldrych F. Gunthard, Karin J. Metzner, Swiss HIV Cohort Study

Summary: A new method was used to analyze HIV-1 DNA, including the detection of drug resistance. The results showed varying levels of drug resistance mutations, which were associated with the duration of antiretroviral therapy.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Gastroenterology & Hepatology

Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort Study

Lukas Baumann, Dominique L. Braun, Matthias Cavassini, Marcel Stoeckle, Enos Bernasconi, Patrick Schmid, Alexandra Calmy, David Haerry, Charles Beguelin, Christoph A. Fux, Gilles Wandeler, Bernard Surial, Andri Rauch

Summary: The study assessed the changes in the prevalence of replicating HCV infection, treatment uptake, and liver-related morbidity and mortality in persons with HIV and hepatitis C. The introduction of direct-acting antiviral therapy was associated with a significant reduction in the prevalence of replicating HCV infection, as well as a decrease in overall mortality and incidence of liver-related events in this population.

LIVER INTERNATIONAL (2023)

Review Immunology

Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies

Eleftheria Kampouri, Jessica S. Little, Kai Rejeski, Oriol Manuel, Sarah P. Hammond, Joshua A. Hill

Summary: CAR-T-cell therapies have greatly improved the treatment of blood cancers, but they come with unique toxicities, especially infections. Infection incidence is highest in the first month after treatment and gradually decreases afterwards. Different CAR-T-cell therapies also result in different types of infections.

TRANSPLANT INFECTIOUS DISEASE (2023)

Article Immunology

Impact of COVID-19 on long-term lung function in lung transplant recipients: A single-center retrospective cohort study

Brice Touilloux, Matthaios Papadimitriou-Olivgeris, Cedric Bongard, Nahal Mansouri, Foteini Ioakeim, Oriol Manuel, Angela Koutsokera, John-David Aubert, Alessio Casutt

Summary: This study examines the long-term lung function in lung transplant recipients after their first SARS-CoV-2 infection. The results show a significant decline in lung function at 3 months, but not at 6 and 12 months post-infection.

TRANSPLANT INFECTIOUS DISEASE (2023)

Article Geriatrics & Gerontology

Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years

Isabella C. Schoepf, Andres Esteban-Cantos, Christian W. Thorball, Berta Rodes, Peter Reiss, Javier Rodriguez-Centeno, Carlotta Riebensahm, Dominique L. Braun, Catia Marzolini, Marco Seneghini, Enos Bernasconi, Matthias Cavassini, Helene Buvelot, Maria Christine Thurnheer, Roger D. Kouyos, Jacques Fellay, Huldrych F. Gunthard, Jose R. Arribas, Bruno Ledergerber, Philip E. Tarr

Summary: In this long-term study, accelerated epigenetic ageing was observed in untreated HIV infection and partial reversal was achieved with effective antiretroviral therapy. It underscores the significance of limiting the duration of untreated HIV infection.

LANCET HEALTHY LONGEVITY (2023)

No Data Available